PKDPaul K. DrainMD, MPH, FIDSAVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Point of Care Tests for Drug Level Testing: Where Are We? - Paul K. Drain, MD, MPH, FIDSAView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Strategies to Improve Delivery to Reservoirs as Targets for Long-Acting Antivirals - Adeniyi Olagunju, BPharm, MRes, PhDView Video
SLHSharon L. HillierPhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Multipurpose Prevention Technologies (MPTs) For Prevention of HIV and Pregnancy - Sharon L. Hillier, PhDView Video
ECEdmund CapparelliPharmDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Pharmacokinetics of mAbs in Prevention, Treatment and Cure of Viral Infections -Edmund Capparelli, PharmDView Video
ACAngela ColbersPhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Optimization of Pharmacology Studies and DDIs in Pregnant and Lactating Individuals -Angela Colbers, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Pharmacology Pearls for Managing Absorption and Swallowing Difficulties - Saye Khoo, MD, PhDView Video
CMCatia MarzoliniPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Age-Related Changes in Pharmacokinetics and Pharmacodynamics - Catia Marzolini, PharmD, PhDView Video
JCJose Castillo-MancillaMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022The Non-adherent Patient: A Good or Bad Candidate for CAB+RPV? - Jose Castillo-Mancilla, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Long-acting Cabotegravir for Treatment and Prevention - M. Boffito, MD, PhD, FRCPView Video
MBMarta BoffitoMD, PhD, FRCP, MBAVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Long-acting Cabotegravir for Treatment and Prevention: When Are You Protected? - M. Boffito, MD, PhD, FRCPView Video
JKJennifer KiserPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022What’s on the Horizon for Direct Acting Antivirals for Hepatitis B? - Jennifer Kiser, PharmD, PhDView Video
SHJScott H. JamesMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022Recent Developments in Antivirals Against Herpes Simplex Virus Infection - Scott H. James, MDView Video
